Jamie Ravitz and Paul Gadiock Co-Author Postmarket Benefits Article for FDLI Update Magazine
The article describes how postmarket medical device benefits can be identified and weighed against emerging device risks. Specifically, it explains how benefit evaluations of off-label device use, patient input, and analyses of “alternatives” may be leveraged to counterbalance a potential medical device safety issue so that the manufacturer can continue marketing the product. To read the article in full, click here.
- Related Industries